Adamis Pharmaceuticals (NASDAQ:ADMP) stock is getting a major boost on Monday thanks to a response from the U.S. Food and Drug Administration (FDA). Source: shutterstock.com/PhotobyTawat This response has the FDA approving Adamis Pharmaceuticals’ ZIMHI. This is a high-dose naloxone injection for the treatment of opioid overdose. It works by “blocking or reversing the effects of…